Feasibility, safety and tolerability of estrogen and/or probiotics for improving vaginal health in Canadian African, Caribbean, and Black women: A pilot phase 1 clinical trial.

MLA

Gill, Biban, et al. “Feasibility, Safety and Tolerability of Estrogen and/or Probiotics for Improving Vaginal Health in Canadian African, Caribbean, and Black Women: A Pilot Phase 1 Clinical Trial.” PloS One, vol. 20, no. 1, Jan. 2025, p. e0315576. EBSCOhost, https://doi.org/10.1371/journal.pone.0315576.

APA

Gill, B., Wessels, J. M., Hayes, C. L., Ratcliffe, J., Wokuri, J., Ball, E., Reid, G., Kaul, R., Rana, J., Alkhaifi, M., Tharao, W., Smaill, F., & Kaushic, C. (2025). Feasibility, safety and tolerability of estrogen and/or probiotics for improving vaginal health in Canadian African, Caribbean, and Black women: A pilot phase 1 clinical trial. PloS One, 20(1), e0315576. https://doi.org/10.1371/journal.pone.0315576

Chicago

Gill, Biban, Jocelyn M Wessels, Christina L Hayes, Jenna Ratcliffe, Junic Wokuri, Elizabeth Ball, Gregor Reid, et al. 2025. “Feasibility, Safety and Tolerability of Estrogen and/or Probiotics for Improving Vaginal Health in Canadian African, Caribbean, and Black Women: A Pilot Phase 1 Clinical Trial.” PloS One 20 (1): e0315576. doi:10.1371/journal.pone.0315576.